Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
General Gastroenterology
Do you accelerate your withdrawal time with the utilization of add-on devices to the colonoscope (such as EndoCuff) that enhance mucosal inspection and polyp detection?
Related Questions
Would you transition a patient with axial spondyloarthritis to a biologic if their axial symptoms were controlled with an NSAID, but they also required a PPI to control dyspepsia/GERD caused by the NSAID?
Based on the recent 2025 "Consensus Recommendations by the US Multi-Society Task Force on Colorectal Cancer", how have you incorporated split prep, simplified preprocedural diet, and use of simethicone into your practice?
How do you approach surveillance of gastric hyperplastic polyps of various sizes?
Has your institution and/or antimicrobial stewardship program incorporated a selective antibiotic approach to treatment of left-sided uncomplicated diverticulitis in immunocompetent patients?
How would you approach management of a patient with a medium-to-large vessel vasculitis who developed perforation of the stomach and colon on steroids and cyclophosphamide?
How would you approach the treatment of a patient with solid food esophageal dysphagia and GERD without a detectable esophageal stricture on upper endoscopy?
Which colonic polyp or mass-like lesions do you refer to an advanced endoscopist?
What inpatient diagnostic workup do you pursue in a patient with an unspecified vomiting disorder who cannot be discharged due to poor PO tolerance?
What sampling techniques do you use to improve the diagnostic yield of biopsies in a patient with suspected vasculitis and extensive scattered ulceration throughout the GI tract?
If you do not have easy access to shear wave elastography (aka Fibroscan), what do you recommend for non-invasive tests to determine if a MASLD patient has clinically significant portal hypertension and risk-stratify them?
